FIVE stock · SRPT stock

FIVE vs SRPT

Five Below Inc (FIVE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.

Five Below Inc (FIVE) is a specialty retail company listed on US.

Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.

Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.

Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.

FIVE currently screens at market cap $7.30B and trailing P/E 27.7. SRPT currently screens at market cap $2.34B.

Not investment advice. Open the FIVE and SRPT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons